[New indications for thalidomide?]

Dtsch Med Wochenschr. 2001 Oct 19;126(42):1178-82. doi: 10.1055/s-2001-17892.
[Article in German]
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Abnormalities, Drug-Induced / etiology
  • Adolescent
  • Adult
  • Angiogenesis Inhibitors / pharmacology
  • Angiogenesis Inhibitors / therapeutic use*
  • Animals
  • Anti-HIV Agents / pharmacology
  • Anti-HIV Agents / therapeutic use*
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Autoimmune Diseases / drug therapy
  • Contraindications
  • Dermatologic Agents / pharmacology
  • Dermatologic Agents / therapeutic use*
  • Erythema Nodosum / drug therapy
  • Female
  • Graft vs Host Disease / drug therapy
  • HIV Infections / drug therapy
  • Hematologic Diseases / drug therapy
  • Humans
  • Immunosuppressive Agents / pharmacology
  • Immunosuppressive Agents / therapeutic use*
  • Infant, Newborn
  • Leprostatic Agents / pharmacology
  • Leprostatic Agents / therapeutic use*
  • Male
  • Multiple Myeloma / drug therapy
  • Neoplasms / drug therapy
  • Pregnancy
  • Rabbits
  • Rats
  • Skin Diseases / drug therapy
  • Thalidomide / administration & dosage
  • Thalidomide / adverse effects
  • Thalidomide / pharmacology
  • Thalidomide / therapeutic use*
  • Time Factors

Substances

  • Angiogenesis Inhibitors
  • Anti-HIV Agents
  • Antineoplastic Agents
  • Dermatologic Agents
  • Immunosuppressive Agents
  • Leprostatic Agents
  • Thalidomide